Search results
CRT 24: The ABSORB Trial
Author(s):
David Power
Added:
1 week ago
Video
Foreword
Author(s):
Ankur Kalra
Added:
3 years ago
Article
Author(s):
David Berg
Added:
1 year ago
ESC Congress 22 — Dr David Berg (Brigham and Women's Hospital, US) shares key results from the TIMI Study Group's COVID-PACT trial (NCT04409834).
This multicenter, randomized-controlled trial assessed efficacy and safety of full-dose vs. standard prophylactic dose anticoagulation and of antiplatelet vs. no antiplatelet therapy for prevention of venous and arterial thrombotic events. The study…
View more
Valve-in-valve TAVR
Author(s):
Emily Perdoncin
,
Gaetano Paone
,
Isida Byku
Added:
1 year ago
Article
Author(s):
Raoul Bonan
,
Anita W Asgar
Added:
3 years ago
Coronary angioplasty has revolutionized the treatment of coronary artery disease. Over the past two decades the field has seen numerous innovations in an attempt to perfect the percutaneous management of coronary atherosclerotic disease. The development of coronary stenting was a major advance in preventing elastic recoil and treating dissections following balloon angioplasty.1 Unfortunately,…
View more
Author(s):
Ahmad Younes
,
Guilherme Ferragut Attizzani
,
Ankur Kalra
Added:
3 years ago
Transcatheter aortic valve replacement (TAVR) is a recent innovation that has transformed the care of patients with symptomatic severe aortic stenosis. It has emerged as an alternative for surgical aortic valve replacement (SAVR) in prohibitive-, high-risk, and more recently, intermediate-risk surgical patients. More than 200,000 TAVRs have been performed in 65 countries around the world.1
As…
View more
Author(s):
Hirotoshi Watanabe
Added:
2 years ago
Dr. Hirotoshi Watanabe (Kyoto University Graduate School of Medicine, JP) discusses the results of the STOPDAPT-2 ACS study. The aim of this study was to assess the safety of reducing dual antiplatelet therapy (DAPT) duration to 1-month after implantation of the everolimus-eluting cobalt-chromium stent (CoCr-EES) under the setting of acute coronary syndrome (ACS).
The trial showed that in ACS…
View more
Added:
5 months ago
Source:
Radcliffe Cardiology
Find out what's hot at TCT in this preview from Prof Nicolas Van Mieghem and Dr Joost Daemen
The Cardiovascular Research Foundation (CRF) has unveiled the late-breaking clinical trials scheduled for presentation at the 2023 Transcatheter Cardiovascular Therapeutics (TCT) annual meeting taking place from October 23 to 26 in San Francisco. TCT is renowned for showcasing groundbreaking research in…
View more
Author(s):
Xiaoyu Yang
,
Mohamed Ahmed
,
Donald E Cutlip
Added:
3 years ago
Over the past 35 years, treatment of coronary artery disease and acute coronary syndrome has changed drastically. Balloon angioplasty offered an early mechanical solution but carried a high risk for acute complications and subsequent restenosis, mainly from recoil. The bare metal stent (BMS) improved restenosis because of recoil, but still carried a relatively high rate of restenosis because of…
View more
Novel Oral Antiplatelet Agents
Author(s):
Suzanne J Baron
,
Robert P Giugliano
Added:
3 years ago
Article